80% increase in dose intensity of cyclophosphamide, epirubicin and fluorouracil does not improve metastatic breast cancer response rate

Alberto Riccardi, Marco Danova

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)193-196
Number of pages4
JournalEvidence-based Oncology
Volume2
Issue number4
DOIs
Publication statusPublished - 2001

ASJC Scopus subject areas

  • Oncology

Cite this

@article{94b668631fdd45d093ba0c2aa17bc8c8,
title = "80{\%} increase in dose intensity of cyclophosphamide, epirubicin and fluorouracil does not improve metastatic breast cancer response rate",
author = "Alberto Riccardi and Marco Danova",
year = "2001",
doi = "10.1054/ebon.2001.0151",
language = "English",
volume = "2",
pages = "193--196",
journal = "Evidence-based Oncology",
issn = "1363-4054",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - 80% increase in dose intensity of cyclophosphamide, epirubicin and fluorouracil does not improve metastatic breast cancer response rate

AU - Riccardi, Alberto

AU - Danova, Marco

PY - 2001

Y1 - 2001

UR - http://www.scopus.com/inward/record.url?scp=0035696937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035696937&partnerID=8YFLogxK

U2 - 10.1054/ebon.2001.0151

DO - 10.1054/ebon.2001.0151

M3 - Article

AN - SCOPUS:0035696937

VL - 2

SP - 193

EP - 196

JO - Evidence-based Oncology

JF - Evidence-based Oncology

SN - 1363-4054

IS - 4

ER -